Pulmonary vein isolation by cryoablation (PVI-C) is a standard therapy for the treatment of atrial fibrillation (AF). The CHA2DS2-VASc score is a well-established predictor of AF-related stroke. Whether the CHA2DS2-VASc score can also be useful in predicting the long-term clinical outcomes following PVI-C is still unsettled. The aim of this analysis was to evaluate the role of the CHA2DS2-VASc score in predicting AF recurrence after PVI-C.
Reference: Role of CHA2DS2-VASc score in predicting atrial fibrillation recurrence in patients undergoing pulmonary vein isolation with cryoballoon ablation.
Rordorf R, Iacopino S, Verlato R, Arena G, Tondo C, Molon G, Manfrin M, Rovaris G, Perego GB, Sciarra L, Mantica M, Sacchi R, Pieragnoli P. J Interv Card Electrophysiol. 2022 Nov 23.